Author’s Reply

Vol. 34 No. 3 (2023): Turkish Journal of Gastroenterology

RE: Risk of HBV Reactivation in HBsAg Negative and AntiHBc IgG Positive Patients Receiving Biologic Therapy

Main Article Content

İlkay Ergenç
Haluk Tarık Kani
Murat Karabacak
Elif Cömert Özer
Shahin Mehdiyev
Fuad Jafarov
Kerem Yiğit Abacar
Seda Kutluğ Ağaçkıran
Gizem Sevik
Rahmi Aslan
Fatma Alibaz Öner
Nevsun İnanç
Mehmet Pamir Atagündüz
Dilek Seçkin
Yeşim Özen Alahdab
Tülin Ergun
Haner Direskeneli
Özlen Atuğ

Abstract

Cite this article as: Ergenç İ, Kani HT, Karabacak M, et al. RE: risk of HBV reactivation in HBsAg negative and anti-HBc IgG positive patients receiving biologic therapy. Turk J Gastroenterol. 2023;34(3):310.

Article Details

Most read articles by the same author(s)

1 2 3 > >>